Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafick-Pierre Sékaly

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Trends in Immunology|November 19, 2024
The immune-endocrine interplay in sex differential responses to viral infection and COVID-19Valentino D'Onofrio, Rafick Pierre Sékaly
Seminars in Immunology|July 27, 2013
Systems immunogenetics of vaccinesMichael Mooney, Shannon McWeeney, Rafick-Pierre Sékaly
Current Opinion in HIV and AIDS|December 3, 2011
Dissecting the HIV-specific immune response: a systems biology approachYoav Peretz, Cheryl Cameron, Rafick-Pierre Sékaly
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2005
A defective viral superantigen-presenting phenotype in HLA-DR transfectants is corrected by CIITAGeorges A Azar, Rafick-Pierre Sékaly, Jacques Thibodeau
Methods in Molecular Biology (Clifton, N.J.)|September 19, 2007
Estimating thymic function through quantification of T-cell receptor excision circlesMarie-Lise Dion, Rafick-Pierre Sékaly, Rémi Cheynier
Current Opinion in Immunology|December 21, 2013
A systems framework for vaccine designMichael Mooney, Shannon McWeeney, Glenda Canderan, et al.
Current Opinion in HIV and AIDS|October 28, 2010
New approaches to design HIV-1 T-cell vaccinesHélène Perrin, Glenda Canderan, Rafick-Pierre Sékaly, et al.
DNA and Cell Biology|February 8, 2006
Cloning and functional characterization of the murine caspase-3 gene promoterLaurent Sabbagh, Martin Bourbonnière, François Denis, et al.
Molecular Immunology|June 14, 2005
Selective up-regulation of caspase-3 gene expression following TCR engagementLaurent Sabbagh, Martin Bourbonnière, Rafick-Pierre Sékaly, et al.
Current Opinion in HIV and AIDS|April 18, 2009
Drug resistance mutations and the cellular immune response: a valuable synergy for the development of novel immune therapiesNicolas Chomont, Lydie Trautmann, Jean-Pierre Routy, et al.
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Trends in Immunology|November 19, 2024
The immune-endocrine interplay in sex differential responses to viral infection and COVID-19Valentino D'Onofrio, Rafick Pierre Sékaly
Seminars in Immunology|July 27, 2013
Systems immunogenetics of vaccinesMichael Mooney, Shannon McWeeney, Rafick-Pierre Sékaly
Current Opinion in HIV and AIDS|December 3, 2011
Dissecting the HIV-specific immune response: a systems biology approachYoav Peretz, Cheryl Cameron, Rafick-Pierre Sékaly
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2005
A defective viral superantigen-presenting phenotype in HLA-DR transfectants is corrected by CIITAGeorges A Azar, Rafick-Pierre Sékaly, Jacques Thibodeau
Methods in Molecular Biology (Clifton, N.J.)|September 19, 2007
Estimating thymic function through quantification of T-cell receptor excision circlesMarie-Lise Dion, Rafick-Pierre Sékaly, Rémi Cheynier
Current Opinion in Immunology|December 21, 2013
A systems framework for vaccine designMichael Mooney, Shannon McWeeney, Glenda Canderan, et al.
Current Opinion in HIV and AIDS|October 28, 2010
New approaches to design HIV-1 T-cell vaccinesHélène Perrin, Glenda Canderan, Rafick-Pierre Sékaly, et al.
DNA and Cell Biology|February 8, 2006
Cloning and functional characterization of the murine caspase-3 gene promoterLaurent Sabbagh, Martin Bourbonnière, François Denis, et al.
Molecular Immunology|June 14, 2005
Selective up-regulation of caspase-3 gene expression following TCR engagementLaurent Sabbagh, Martin Bourbonnière, Rafick-Pierre Sékaly, et al.
Current Opinion in HIV and AIDS|April 18, 2009
Drug resistance mutations and the cellular immune response: a valuable synergy for the development of novel immune therapiesNicolas Chomont, Lydie Trautmann, Jean-Pierre Routy, et al.
Pageof 9